Monoamine oxidases are major mechanisms by which norepinephrine, epinephrin and serotonin are degraded (Tipton, 2018), and clorgyline, a specific, irreversible inhibitor of MAOA have been used in the treatment of depression for many years (Lipper et al., 1979). Here, MAOA is linked to major depressive disorder.